Excerpt from symptoms and conditions

Even more information regarding subcutaneous atrophy and the class of drugs which Kenalog fall in to:

"Subcutaneous atrophy developed in a 36-year-old woman at the site of a triamcinolone acetonide (Kenalog) injection for subdeltoid bursitis. Occurrence of local atrophy after corticosteroid injection is relatively frequent yet unappreciated. It is more common in young women and girls who are given preparations with a lesser degree of water solubility. Although the condition is often reversible, instances of long-term disfigurement are well documented. This complication of a useful treatment method can be avoided by following a set of precautions for local injection of corticosteroids."

The above excerpt from a 1986 article in the U.S National Library of Medicine. There is also an article as far back as 1967 in the British Medical Journal (10/14/1967) that puts forward the same theory (though it is argued about in the editorial of the Journal).

Anyone who has experienced this problem should print this out and show it to their doctors. Presumably and hopefully your doctor is aware of medical journals and respects the DATA!